Ironically, one of the forces that push back against that are the much-derided health insurance companies. Health insurance has the exact opposite incentive structure, they prefer a cure over an ongoing treatment.
Also, do you think the owners and executives of pharma companies never get cancer themselves, or never have friends and family with cancer?
In reality the reasons why cures are less common than treatments are complex, it’s not pure evil motivating it. Cures are just hard. Especially for something like cancer, which is not just one single disease but rather an whole vast constellation of different diseases. Some kinds of cancer have been cured, and new cures keep coming out all the time. We just haven’t done them all yet.
I keep telling these people this. Any cure for cancer is going to make it to market because there’s money to be made. If there’s money to be made, somebody is gonna make it, even if it’s not the people making the current treatments who stand to lose out.
Cures don’t come with a subscription model.
Ironically, one of the forces that push back against that are the much-derided health insurance companies. Health insurance has the exact opposite incentive structure, they prefer a cure over an ongoing treatment.
Also, do you think the owners and executives of pharma companies never get cancer themselves, or never have friends and family with cancer?
In reality the reasons why cures are less common than treatments are complex, it’s not pure evil motivating it. Cures are just hard. Especially for something like cancer, which is not just one single disease but rather an whole vast constellation of different diseases. Some kinds of cancer have been cured, and new cures keep coming out all the time. We just haven’t done them all yet.
I keep telling these people this. Any cure for cancer is going to make it to market because there’s money to be made. If there’s money to be made, somebody is gonna make it, even if it’s not the people making the current treatments who stand to lose out.
Also the clout for releasing a cancer cure. It would definitely boost the company’s valuation.